Congenital Heart Disease
Leading citation impact metric from Clarivate Journal Citation Reports
36 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 1.50đ | WoS Q3(IF: 2.3) | 🔵 Computed |
| 2025 | 1.50đ | WoS Q3(IF: 1.2) | 🔵 Computed |
| 2024 | 1.50đ | WoS Q3(IF: 0.3) | 🔵 Computed |
| 2023 | 1.50đ | WoS Q3(IF: 0.3) | 🔵 Computed |
| 2022 | 1.50đ | WoS Q3(IF: 2.419) | 🔵 Computed |
| 2021 | 1.50đ | WoS Q3(IF: 2.007) | 🔵 Computed |
| 2020 | 1.50đ | WoS Q3(IF: 1.663) | 🔵 Computed |
| 2019 | 1.50đ | WoS Q3(IF: 2.036) | 🔵 Computed |
| 2018 | 1.50đ | WoS Q3(IF: 1.995) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Congenital Heart Disease is an open-access journal focusing on congenital heart disease in children and adults. Though the number of infants born with heart disease each year is relatively small (approximately 1% of the population), advances in treating such malformations have led to increased life spans for this population. Consequently, today most patients treated for congenital heart disease are over the age of 20. What are the special needs of adults with congenital heart disease? What are the latest developments in the care of the fetus, infants, and children? Who should treat these patients? How should they be treated? Congenital Heart Disease focuses on these questions and more. Conceived as a forum for the most up-to-date information on congenital heart disease, the journal is led by Editor-in-Chief Vladimiro L. Vida, MD, Ph.D., Professor in Cardiac Surgery, University of Padua in Italy, as well as an international editorial board. Congenital Heart Disease publishes articles on heart disease as it relates to the following areas: • Basic research of congenital heart disease • Clinical pediatric and adult cardiology • Cardiac imaging • Preventive cardiology • Diagnostic and interventional cardiac catheterization • Electrophysiology • Surgery • Long-term follow-up, particularly as it relates to older children and adult congenital heart disease • Exercise and exercise physiology in the congenital patient • Post-op and critical care • Common disorders such as syncope, chest pain, murmurs, as well as acquired disorders such as Kawasaki syndrome The journal includes clinical studies, invited editorials, state-of-the-art reviews, case reports, articles focusing on the history and development of congenital heart disease, and CME material. Occasional issues focus on special topics. Readership: Congenital Heart Disease was created for pediatric cardiologists; adult cardiologists who care for patients with congenital heart disease; pediatric and pediatric cardiology nurses; surgeons; radiologists; anesthesiologists; critical care physicians and nurses; and adult support staff involved in the care of patients with congenital heart disease.
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Measures cumulative publication volume and citation impact.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
CARDIAC & CARDIOVASCULAR SYSTEMS | JCRSCIE | 125/237 | Q3 |
CARDIAC & CARDIOVASCULAR SYSTEMS | JCISCIE | 174/237 | Q3 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2025 | 1.2 | 63 | 35 |
| 2024 | 0.3 | 55 | 95 |
| 2023 | 0.3 | 51 | 296 |
| 2022 | 2.419 | 89 | 99 |
| 2021 | 2.007 | 61 | 107 |
| 2020 | 1.663 | 53 | 115 |
| 2019 | 2.036 | 140 | 2,526 |
| 2018 | 1.995 | 179 | 2,891 |
| 2017 | — | 130 | 2,298 |
| 2016 | — | 114 | 2,489 |
| 2015 | — | 116 | 1,788 |
| 2014 | — | 99 | 2,309 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Congenital Heart Disease
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics